14. 5. 2026
Krka Reports First Quarter 2026 Business Results
2 min. read
In the first quarter of 2026, the Krka Group generated revenue of €565.8 million and operating profit of €151.6 million, confirming long-term stable sales growth and sustained operating profitability. EBITDA margin stood at 31%. The Supervisory Board of Krka discussed the Q1 2026 business report of the Krka Group and Krka at its regular meeting yesterday.
President of the Management Board and Chief Executive Officer Jože Colarič explained: ‘We continued to operate successfully in the first quarter of 2026. Product and service sales increased by 8%. We recorded growth in most markets and across all product and service groups, with the exception of non-prescription products. It is important that we continue to strengthen sales and our position in our key sales regions and traditional markets. We expanded our product portfolio with three new prescription pharmaceuticals and one animal health product. For the first time, operating profit in a single quarter exceeded €150 million, up 24% year on year. Net profit for the first quarter amounted to €121 million, which was the second highest to date in Krka. Year-on-year net profit decreased by 21%, on the back of a high base effect of net financial result in the first quarter last year, while net financial result presented a slight loss this year. Compared to an average quarter of the previous year, net profit increased by 20%. We continue a range of investment projects, upgrading and expanding the capacities in Slovenia and abroad.
Financial highlights
| € thousand | Index | ||
| Revenue | 565,774 | 522,114 | 108 |
| – Of which revenue from products and services | 564,195 | 521,456 | 108 |
| Gross profit | 342,001 | 304,417 | 112 |
| Earnings before interest, tax, depreciation and amortisation (EBITDA) | 175,650 | 145,862 | 120 |
| Operating profit (EBIT) | 151,601 | 122,690 | 124 |
| Profit before tax (EBT) | 148,272 | 179,514 | 83 |
| Net profit | 120,950 | 152,484 | 79 |
| R&D expenses | 51,371 | 49,519 | 104 |
| Investments | 22,942 | 21,066 | 109 |
Performance ratios
| Gross profit margin | 60.4% | 58.3% |
| EBITDA margin | 31.0% | 27.9% |
| EBIT margin | 26.8% | 23.5% |
| EBT margin | 26.2% | 34.4% |
| Net profit margin (ROS) | 21.4% | 29.2% |
| Return on equity (ROE) | 19.9% | 26.2% |
| Return on assets (ROA) | 15.6% | 20.5% |
| Liabilities/Equity | 0.278 | 0.276 |
| R&D expenses/Revenue | 9.1% | 9.5% |
Sales
Product and service sales by Region
Region Slovenia,6.1
Region South-East Europe,14.49
Region East Europe,35.5
Region Central Europe,23.7
Region West Europe,16.8
Region Overseas Markets,3.4